Folger Hill Asset Management’s Teladoc Health TDOC Stock Holding History

Folger Hill Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-140,000	Closed	-$5.64M	–	156
2018 Q1	$5.64M	Buy	140,000 +102,500	+273%	+$3.87M	0.38%	81
2017 Q4	$1.31M	Buy	+37,500	New	+$1.25M	0.13%	146

Other funds holding TDOC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Folger Hill Asset Management's TDOC Position: Q2 2018 in Review

Folger Hill Asset Management sold out of Teladoc Health (TDOC) in Q2 2018, closing a stake of 140,000 shares — an estimated $5.64M sold.

Folger Hill Asset Management first reported a position in TDOC in Q4 2017 and held it in 2 quarters. The position peaked at $5.64M in Q1 2018. 275 funds tracked by Wall St. Rank hold TDOC as of Q2 2018.

Folger Hill Asset Management reported no remaining Teladoc Health position as of Q2 2018 after selling out during the quarter.
Folger Hill Asset Management sold 140,000 Teladoc Health shares in Q2 2018, an estimated $5.64M.
Folger Hill Asset Management first reported a position in Teladoc Health in Q4 2017 and held it in 2 quarters.
Folger Hill Asset Management's Teladoc Health position peaked at $5.64M in Q1 2018.
275 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2018.

Based on Folger Hill Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.